Evidence map›Paper›PMID 38762596›Full record

ArticleCell death and differentiation2024

PPA1 promotes adipogenesis by regulating the stability of C/EBPs.

Yangyang Wu, Yue Sun, Yuqing Song, Jiateng Wang, Ye Han, Nan Yang, Haiyan Lin, Ye Yin, Xiao Han

Abstract read
In one paragraph

Article in Cell death and differentiation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yangyang Wu *Key Laboratory of Human Functional Genomics of Jiangsu Province, Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, Jiangsu, China.
Yue Sun *Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Yuqing SongKey Laboratory of Human Functional Genomics of Jiangsu Province, Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, Jiangsu, China.
Jiateng WangKey Laboratory of Human Functional Genomics of Jiangsu Province, Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, Jiangsu, China.
Ye HanKey Laboratory of Human Functional Genomics of Jiangsu Province, Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, Jiangsu, China.
Nan YangKey Laboratory of Human Functional Genomics of Jiangsu Province, Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, Jiangsu, China.
Haiyan LinKey Laboratory of Human Functional Genomics of Jiangsu Province, Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, Jiangsu, China. linda@njmu.edu.cn.ORCID 0009-0005-9709-0755
Ye YinKey Laboratory of Human Functional Genomics of Jiangsu Province, Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, Jiangsu, China. yin@njmu.edu.cn.ORCID 0009-0005-0980-6646
Xiao HanKey Laboratory of Human Functional Genomics of Jiangsu Province, Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, Jiangsu, China. hanxiao@njmu.edu.cn.ORCID 0000-0002-6467-1802

Funding

National Natural Science Foundation of China (National Science Foundation of China) 81870566National Natural Science Foundation of China (National Science Foundation of China) 81970709National Natural Science Foundation of China (National Science Foundation of China) 82270874
6 · The paper itself

Abstract

Adipogenesis significantly contributes to healthy adipose tissue expansion in obesity. Increasing adipocyte number or function to alleviate adipose tissue overload could serve as a therapeutic strategy for both lipodystrophy and obesity-related metabolic syndrome. Inorganic pyrophosphatase (PPA1) is an enzyme that catalyzes the hydrolysis of pyrophosphate (PPi) and is involved in many biochemical reactions, but its function in adipose tissue has not been studied previously. In this study, we demonstrated that adipose-specific PPA1 knockout (PPA1

Indexed as

3T3-L1 CellsAdipogenesisCCAAT-Enhancer-Binding ProteinsAdipocytesAnimalsCCAAT-Enhancer-Binding Protein-betaCCAAT-Enhancer-Binding Protein-deltaCell DifferentiationHumansInorganic PyrophosphataseInsulin ResistanceMaleMiceMice, Inbred C57BLMice, KnockoutObesityCCAAT-Enhancer-Binding Protein-betaCCAAT-Enhancer-Binding Protein-deltaCCAAT-Enhancer-Binding ProteinsCebpb protein, mouseCebpd protein, mouseInorganic PyrophosphatasePpa1 protein, mousePyrophosphatases

Identifiers

PMID38762596
PMCPMC11303681

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.